Dr Roger K Amundson, DC in Malta, MT - Chiropractor

Dr Roger K Amundson, DC is a Chiropractor based in Malta, Montana. Dr Roger K Amundson is licensed to practice in Montana (license number 534) and his current practice location is 830 South Central Ave, Malta, Montana. He can be reached at his office (for appointments etc.) via phone at (406) 654-1130.

NPI number for Dr Roger K Amundson is 1699843656 and his current mailing address is P.o. Box 688, Malta, Montana. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1699843656.

Contact Information

	Dr Roger K Amundson, DC
	830 South Central Ave, Malta, MT 59538
	(406) 654-1130
	Not Available

Healthcare Provider's Profile

Full Name	Dr Roger K Amundson
Gender	Male
Speciality	Chiropractor
Location	830 South Central Ave, Malta, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1699843656
Provider Enumeration Date: 11/30/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Roger K Amundson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1699843656	NPI	-	NPPES
534	Other	MT	MONTANA LICENSE NUMBER

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
111N00000X	Chiropractor	534 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Roger K Amundson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Roger K Amundson, DC P.o. Box 688, Malta, MT 59538 Ph: (406) 654-1130	Dr Roger K Amundson, DC 830 South Central Ave, Malta, MT 59538 Ph: (406) 654-1130

News Archive

Joint research by UB and CDC could lead to new generation of antiviral medicines

Future pandemics of seasonal flu, H1N1 and other drug-resistant viruses may be thwarted by a potent, immune-boosting payload that is effectively delivered to cells by gold nanorods, report scientists at the University at Buffalo and the U.S. Centers for Disease Control and Prevention. The work is published in the current issue of the Proceedings of the National Academy of Sciences.

Vertex initiates OPTIMIZE Phase 3b study in patients infected with genotype 1 HCV

Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 3b study called OPTIMIZE that will evaluate twice-daily (BID) dosing of a telaprevir-based combination regimen in people chronically infected with genotype 1 hepatitis C virus (HCV) who have not been treated previously. This is the first Phase 3 study to evaluate twice-daily dosing of a protease inhibitor for the treatment of hepatitis C. OPTIMIZE will not include a control arm of pegylated-interferon and ribavirin alone.

Study broadens understanding of how cells regulate X chromosome inactivation

In a paper published in the Nov. 21 issue of Cell, a team led by Mauro Calabrese, a postdoctoral fellow at the University of North Carolina in the lab of Terry Magnuson, chair of the department of genetics and member of the UNC Lineberger Comprehensive Cancer Center, broadens the understanding of how cells regulate silencing of the X chromosome in a process known as X-inactivation.

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

Researchers track the wellbeing of British population before and during COVID-19 pandemic

The coronavirus outbreak caused life satisfaction to fall sharply, but lockdown went a long way to restoring contentment - even reducing the "wellbeing inequality" between well-off professionals and the unemployed, according to a new study.

Dr Roger K Amundson, DC - Chiropractor in Malta, MT